Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03639025 · ClinicalTrials.gov registry record
OCS™ Lung TOP Registry For Donor Lungs for Transplantation
A clinical trial of Lung Transplantation, sponsored by TransMedics.
- Active
- Registry status
- 458
- Enrollment target
- 18
- Study locations
NCT03639025 is a study of Lung Transplantation that is active but no longer recruiting, run by TransMedics. The registered enrollment target is 458 participants, above the 298-participant average among 12 other Lung Transplantation trials with a reported enrollment target (54% higher). The trial reports 18 study locations across 14 states.
The verdict
NCT03639025, a study of Lung Transplantation, is active but no longer recruiting, sponsored by TransMedics.
- ACTIVE NOT RECRUITING
- Registry status
- 458 participants
- Enrollment target
- 18
- Study locations
Study Summary
Single-arm, prospective, multi-center, post-approval U.S. registry
Conditions Studied
Interventions
- DEVICE OCS Lung System
Study Locations (18)
California
- UCLA - Los Angeles
- Stanford University - Palo Alto
- UCSF - San Francisco
Texas
- Baylor Scott & White Research Institute - Dallas
- Baylor St. Luke's Medical Center - Houston
- Houston Methodist - Houston
Arizona
- St. Joseph's Hospital and Medical Center - Phoenix
Florida
- Tampa General Hospital - Tampa
Georgia
- Emory - Atlanta
Illinois
- University of Chicago - Chicago
Maryland
- Johns Hopkins - Baltimore
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 458 participants |
| Start Date | 2018-12-10 |
| Est. Completion | 2029-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03639025
The ClinicalTrials.gov registry entry for NCT03639025 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 458 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 298-participant average among 12 other Lung Transplantation trials with a reported enrollment target (54% higher). The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Transplantation appearing as the primary indexed condition, and to 1 intervention - of which OCS Lung System is the first listed.
NCT03639025 reports 18 study locations spanning 14 distinct geographic areas - top geographies include California, Texas, Arizona.
Frequently Asked Questions
What is clinical trial NCT03639025 about?
NCT03639025 is a clinical study titled "OCS™ Lung TOP Registry For Donor Lungs for Transplantation". Single-arm, prospective, multi-center, post-approval U.S. registry
What is the current status of trial NCT03639025?
This trial is currently active not recruiting. The enrollment target is 458 participants. The study started on 2018-12-10. Estimated completion is 2029-11-30.
What conditions does trial NCT03639025 study?
This clinical trial studies the following conditions: Lung Transplantation.
What interventions are being tested in trial NCT03639025?
The interventions under investigation include: OCS Lung System (DEVICE).
Who is sponsoring clinical trial NCT03639025?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03639025 being conducted?
This trial has 18 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation
RECRUITING
-
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
RECRUITING · Phase 2
-
Trifecta-Lung cfDNA-MMDx Study
RECRUITING
-
Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
RECRUITING
-
Transplanting Lungs From Uncontrolled Donation After Circulatory Death
RECRUITING · NA
-
This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.